Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
DISCH AG is a contract development and manufacturing organization (CDMO) based in Othmarsingen, Switzerland, rather than a typical SaaS or enterprise software company. With more than 120 years of confectionery technology experience, the company has strategically shifted its focus toward pharmaceutical manufacturing since 2003. Its customers include pharmaceutical companies, dietary supplement brands, food-industry clients, and large retail chains. Its core positioning is the development and production of specialized solid dosage forms for OTC medicines and dietary supplements based on confectionery processes.
Based on the site content, DISCH provides an end-to-end service chain covering product concept, dosage-form development, raw material selection, packaging evaluation, formulation development, laboratory samples, scale-up trials, process capability studies, stability studies, and process/packaging/cleaning validation. Dosage forms include lozenges, soft chewable tablets, pastilles, gummies, and related formats. On the quality side, the website highlights its internal quality system, GMP standards, Swissmedic approval/certification, and also mentions certification information related to the FDA and Russian Authorities. It also has capabilities in quality testing, stability studies, and test-method development.
The website does not disclose packages, pricing, minimum order quantities, project timelines, or a standard quotation model. As this is a customized CDMO service, commercial terms are typically quoted individually based on product complexity, dosage form, validation requirements, packaging, batch size, and regulatory pathway. Contact channels mainly include phone, email, and business contacts; there is no visible online self-service ordering, customer portal, API, or developer documentation.
Its strengths include local Swiss production, long-standing confectionery process know-how, interdisciplinary teams spanning pharmaceuticals and food, and one-stop service from R&D to market launch. It is suitable for customers with high requirements for quality, compliance, and specialized oral dosage forms. The drawbacks are that the website is more focused on brand and capability presentation, with limited information on commercial terms, case data, digital collaboration platforms, permission management, system integration, or other enterprise-software-style details. For overseas customers, especially Chinese customers, registration, logistics, payment, and local support are also not clearly explained.
DISCH is better suited to pharmaceutical and nutrition brands looking to develop OTC lozenges, gummy-style supplements, soft chewable dosage forms, or white-label products. The available content does not make it possible to assess access from China, and payment methods are not disclosed. If a Chinese company plans to procure from DISCH, it should carefully verify cross-border regulatory registration, sample shipping, payment currency, quality audits, language communication, and whether domestic alternative CDMOs can meet similar dosage-form requirements.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on disch.ch official site.
disch.ch is an Switzerland SaaS provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach disch.ch directly.